Company · CIK 0001709401
Rubius Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/ARubius Therapeutics, Inc.0000315066-23-002230 · 8.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-042792 · 198.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-028428 · 204.8 KBSEC(opens sec.gov)
- SC 13G/ARubius Therapeutics, Inc.0001088875-23-000072 · 10.8 KBSEC(opens sec.gov)
- 10-KAnnual report0001709401-23-000005 · 7.6 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-024013 · 238.9 KBSEC(opens sec.gov)
- SC 13G/ARubius Therapeutics, Inc.0001193125-23-038310 · 160.7 KBSEC(opens sec.gov)
- SC 13G/ARubius Therapeutics, Inc.0000315066-23-002039 · 8.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-011161 · 252.4 KBSEC(opens sec.gov)
- SC 13G/ARubius Therapeutics, Inc.0001088875-23-000033 · 11.2 KBSEC(opens sec.gov)
Insiders
- AFEYAN NOUBARDirector, 10% Owner
- Appelhans DannielleCEO and President
- CAGNONI PABLO JDirector
- Carmona JoseChief Financial Officer
- CARPENTER CHRISTOPHER L.Chief Medical Officer
- Coughlin Christina M.Chief Medical Officer
- Cuss Francis MDirector
- Epstein David RDirector
- Flagship VentureLabs IV, LLC10% Owner
- Flagship Ventures Fund IV General Partner LLC10% Owner
Tickers
No tickers on record.
Addresses
business
C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101
FOXBORO, MA, 02035
mailing
C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101
FOXBORO, MA, 02035
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies